Glenmede Trust Co. NA Cuts Stock Holdings in Synopsys, Inc. $SNPS

Glenmede Trust Co. NA lessened its position in Synopsys, Inc. (NASDAQ:SNPS) by 17.8% during the 1st quarter, HoldingsChannel.com reports. The fund owned 14,609 shares of the semiconductor company’s stock after selling 3,173 shares during the quarter. Glenmede Trust Co. NA’s holdings in Synopsys were worth $5,792,000 at the end of the most recent reporting period.

Other institutional investors have also recently made changes to their positions in the company. Sankala Group LLC purchased a new position in Synopsys in the 4th quarter valued at $25,000. Thurston Springer Miller Herd & Titak Inc. acquired a new stake in Synopsys during the 4th quarter worth $28,000. Caitong International Asset Management Co. Ltd purchased a new stake in shares of Synopsys during the fourth quarter worth $28,000. IMG Wealth Management Inc. purchased a new stake in shares of Synopsys during the first quarter worth $30,000. Finally, Atlas Capital Advisors Inc. acquired a new stake in shares of Synopsys in the fourth quarter valued at about $32,000. 85.47% of the stock is owned by institutional investors and hedge funds.

Insider Activity

In related news, CEO Sassine Ghazi sold 14,603 shares of the company’s stock in a transaction that occurred on Monday, June 15th. The stock was sold at an average price of $458.96, for a total value of $6,702,192.88. Following the transaction, the chief executive officer directly owned 75,020 shares in the company, valued at approximately $34,431,179.20. This represents a 16.29% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CFO Shelagh Glaser sold 3,394 shares of the stock in a transaction that occurred on Friday, June 12th. The stock was sold at an average price of $450.02, for a total value of $1,527,367.88. Following the completion of the transaction, the chief financial officer owned 14,358 shares of the company’s stock, valued at $6,461,387.16. The trade was a 19.12% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 0.56% of the company’s stock.

Synopsys Stock Up 0.9%

NASDAQ SNPS opened at $392.07 on Tuesday. Synopsys, Inc. has a 52 week low of $366.00 and a 52 week high of $636.61. The company has a quick ratio of 1.32, a current ratio of 1.43 and a debt-to-equity ratio of 0.33. The business’s fifty day simple moving average is $441.23 and its 200-day simple moving average is $449.25. The firm has a market cap of $75.07 billion, a PE ratio of 90.76, a P/E/G ratio of 2.28 and a beta of 1.22.

Synopsys (NASDAQ:SNPS) last announced its quarterly earnings data on Wednesday, May 27th. The semiconductor company reported $3.35 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $3.15 by $0.20. Synopsys had a net margin of 8.91% and a return on equity of 5.83%. The firm had revenue of $2.28 billion during the quarter, compared to analyst estimates of $2.25 billion. During the same quarter in the prior year, the firm posted $3.67 earnings per share. Synopsys’s quarterly revenue was up 41.9% on a year-over-year basis. Synopsys has set its FY 2026 guidance at 14.720-14.800 EPS and its Q3 2026 guidance at 3.630-3.690 EPS. As a group, equities analysts anticipate that Synopsys, Inc. will post 10.65 earnings per share for the current year.

Wall Street Analyst Weigh In

SNPS has been the topic of several research reports. Zacks Research raised shares of Synopsys from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, June 30th. Piper Sandler raised shares of Synopsys from a “neutral” rating to an “overweight” rating and upped their price objective for the company from $450.00 to $550.00 in a research note on Tuesday, June 23rd. Needham & Company LLC reiterated a “buy” rating and issued a $580.00 price objective on shares of Synopsys in a report on Thursday, May 28th. Weiss Ratings reissued a “hold (c-)” rating on shares of Synopsys in a research note on Monday, June 8th. Finally, KeyCorp restated an “overweight” rating on shares of Synopsys in a report on Thursday, May 28th. Two equities research analysts have rated the stock with a Strong Buy rating, ten have issued a Buy rating, five have issued a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $570.06.

About Synopsys

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.